<DOC>
	<DOCNO>NCT01751126</DOCNO>
	<brief_summary>The objective study compare efficacy two different dose regimen NOVA22007 ( 1mg/ml ciclosporin/cyclosporine ) eye drop , emulsion versus placebo ( vehicle formulation ) administer four time day patient severe vernal keratoconjunctivitis 4 month treatment .</brief_summary>
	<brief_title>Double-Masked Trial NOVA22007 ( 1mg/mL Ciclosporin/Cyclosporine ) Versus Vehicle Pediatric Patients With Active Severe Vernal Keratoconjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Males females 4 less 18 year age . History least one recurrence vernal keratoconjunctivitis ( VKC ) past year prior enrolment . Patients receive treatment establish active VKC ; patient already receive treatment VKC provide treatment stop accord washout period specify exclusion criterion . Active severe VKC consistent grade 3 4 Bonini scale ( Bonini 2007 ) severe keratitis ( grade 4 5 modify Oxford scale ) . Mean score 4 subjective symptom ( photophobia , tear , itch mucous discharge ) ≥ 60 mm use 100 mm Visual Analogue Scale ( `` 0 '' mean symptom `` 100 '' mean worst ever experience ) . Any relevant ocular anomaly VKC interfere ocular surface include trauma , post radiation keratitis , severe blepharitis , rosacea , corneal ulcer etc . Abnormal lid anatomy , abnormality nasolacrimal drainage system blink function either eye . Active herpes keratitis history ocular herpes . Active ocular infection ( viral , bacterial , fungal , protozoal ) . Any ocular disease VKC require topical ocular treatment course study . Contact lenses wear study . Topical and/or systemic use corticosteroid within one week prior enrolment . Topical ciclosporin ( e.g . Restasis® ) , tacrolimus sirolimus within 90 day prior enrolment . Scraping vernal plaque within one month prior Baseline visit . Ocular surgery within 6 month prior Baseline visit ( exclude surgical treatment vernal plaque ) . Disease stabilize within 30 day Baseline Visit ( e.g. , diabetes glycemia range , thyroid malfunction , uncontrolled autoimmune disease , current systemic infection ) judge investigator incompatible study . Presence history severe systemic allergy . Any systemic immunosuppressant drug within 90 day Baseline Visit . Known hypersensitivity one component study procedural medication ( e.g. , fluorescein , etc ) . History malignancy last 5 year . Pregnancy lactation Baseline Visit . History ocular varicellazoster vaccinia virus infection .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>vernal keratoconjunctivitis</keyword>
	<keyword>ciclosporin</keyword>
	<keyword>cyclosporine</keyword>
</DOC>